W Keitel

Baylor College of Medicine — United States

Medicine · Health Sciences

20h-index4.2kcitations59works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Influenza Virus Research Studies(17), Respiratory viral infections research(11), Monoclonal and Polyclonal Antibodies Research(7), SARS-CoV-2 and COVID-19 Research(6), Rheumatoid Arthritis Research and Therapies(5)

Publications59 total

A phase 1 study of the safety, reactogenicity, and immunogenicity of a Schistosoma mansoni vaccine with or without glucopyranosyl lipid A aqueous formulation (GLA-AF) in healthy adults from a non-endemic area
Vaccine·2019· 64 citedOpen Access
Effect of recent seasonal influenza vaccination on serum antibody responses to candidate pandemic influenza A/H5N1 vaccines: A meta-analysis
Vaccine·2019· 8 cited
Conclusions and Perspectives
2019Open Access
Long-term Persistence of Zoster Vaccine Efficacy
Clinical Infectious Diseases·2014· 292 citedOpen Access
Impact of Body Mass Index on Immunogenicity of Pandemic H1N1 Vaccine in Children and Adults
The Journal of Infectious Diseases·2014· 51 citedOpen Access
Influenza A(H5N1) Vaccines: Are We Better Prepared for the Next Pandemic?
The Journal of Infectious Diseases·2013· 8 citedOpen Access
Front & Back Matter
Public Health Genomics·2013
Investigators' Perspectives on Translating Human Microbiome Research into Clinical Practice
Public Health Genomics·2013· 3 citedOpen Access
Direct Comparison of an Inactivated Subvirion Influenza A Virus Subtype H5N1 Vaccine Administered by the Intradermal and Intramuscular Routes
The Journal of Infectious Diseases·2012· 20 citedOpen Access
Safety and Immunogenicity of a Recombinant Nonglycosylated Erythrocyte Binding Antigen 175 Region II Malaria Vaccine in Healthy Adults Living in an Area Where Malaria Is Not Endemic
Clinical and Vaccine Immunology·2010· 68 citedOpen Access
Comparative immunogenicity of recombinant influenza hemagglutinin (rHA) and trivalent inactivated vaccine (TIV) among persons ≥65 years old
Vaccine·2009· 64 cited
Safety, reactogenicity and immunogenicity of Francisella tularensis live vaccine strain in humans
Vaccine·2009· 49 cited
Preparing for a possible pandemic: influenza A/H5N1 vaccine development
Current Opinion in Pharmacology·2007· 20 cited
Safety and Immunogenicity of Nonadjuvanted and MF59-Adjuvanted Influenza A/H9N2 Vaccine Preparations
Clinical Infectious Diseases·2006· 149 citedOpen Access
Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: A randomized, double-blinded, controlled, multicenter trial
Vaccine·2006· 105 cited
A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults
New England Journal of Medicine·2005· 2.4k citedOpen Access
Epstein-Barr Virus DNA Loads in Adult Human Immunodeficiency Virus Type 1-Infected Patients Receiving Highly Active Antiretroviral Therapy
Clinical Infectious Diseases·2003· 74 citedOpen Access
Phase I trial of two recombinant vaccines containing the 19kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (msp-119) and T helper epitopes of tetanus toxoid
Vaccine·1999· 84 cited
Safety and immunogenicity of two recombinant vaccines based upon plasmodium falciparum merozoite surface protein 1 (P30P2 MSP-1 191 19)
1997
Increasing doses of purified influenza virus hemagglutinin and subvirion vaccines enhance antibody responses in the elderly
Clinical and Diagnostic Laboratory Immunology·1996· 57 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Robert L. Atmar(12), T. R. Cate(9), R. B. Couch(7), Hana M. El Sahly(7), Shital M. Patel(6), Howard R. Six(4), Kenneth E. Schmader(3), J C Guatelli(3), C. T. Pachucki(3), S. Keay(3), W. Paul Glezen(3), R. B. Couch(3), Kathryn M. Edwards(3), Michael N. Oxman(2), Myron J. Levin(2), Gary R. Johnson(2), Kathy D. Boardman(2), Carol A. Kauffman(2), Robert F. Betts(2), Marie R. Griffin(2)